Incyte (INCY) Financials

$62.11 -0.42 (-0.67%)

Closing price 04:00 PM Eastern

Extended Trading

$62.00 -0.11 (-0.18%)

As of 07:35 PM Eastern

Annual Income Statements for Incyte

This table shows Incyte's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	6.53	104	-313	109	447	-296	949	341	598	33
Consolidated Net Income / (Loss)	6.53	104	-313	109	447	-296	949	341	598	33
Net Income / (Loss) Continuing Operations	6.53	104	-313	109	447	-296	949	341	598	33
Total Pre-Tax Income	7.56	107	-312	115	487	-232	570	529	834	317
Total Operating Income	51	145	-243	129	402	-264	586	579	621	61
Total Gross Profit	727	1,048	1,457	1,788	2,045	2,535	2,835	3,188	3,441	3,929
Total Revenue	754	1,106	1,536	1,882	2,159	2,667	2,986	3,395	3,696	4,241
Operating Revenue	754	1,106	1,536	1,882	2,159	2,667	2,986	3,395	3,696	4,241
Total Cost of Revenue	27	58	79	94	114	131	151	207	255	312
Operating Cost of Revenue	27	58	79	94	114	131	151	207	255	312
Total Operating Expenses	676	903	1,700	1,659	1,643	2,799	2,249	2,608	2,820	3,868
Selling, General & Admin Expense	197	303	366	434	469	517	740	1,002	1,161	1,242
Research & Development Expense	480	582	1,326	1,198	1,154	2,216	1,458	1,586	1,628	2,607
Other Operating Expenses / (Income)	-	-	-	0.00	0.00	43	37	7.97	2.05	-1.03
Other Special Charges / (Income)	0.00	17	7.70	26	20	23	15	12	29	20
Total Other Income / (Expense), net	-43	-38	-69	-14	85	31	-15	-50	214	255
Interest Expense	46	39	62	1.54	1.86	2.17	1.91	2.67	2.55	2.28
Interest & Investment Income	7.09	1.15	-24	-44	34	10	-24	40	202	245
Other Income / (Expense), net	-4.58	-	17	32	52	23	11	-88	14	13
Income Tax Expense	1.03	3.18	0.85	5.85	40	63	-378	188	237	284
Basic Earnings per Share	$0.04	$0.55	($1.53)	$0.52	$2.08	($1.36)	$4.30	$1.53	$2.67	$0.16
Weighted Average Basic Shares Outstanding	179.60M	187.87M	204.58M	212.38M	214.91M	218.07M	220.43M	222.00M	223.63M	207.11M
Diluted Earnings per Share	$0.03	$0.54	($1.53)	$0.51	$2.05	($1.36)	$4.27	$1.52	$2.65	$0.15
Weighted Average Diluted Shares Outstanding	187.30M	194.13M	204.58M	215.64M	217.66M	218.07M	222.07M	223.96M	225.93M	210.53M
Weighted Average Basic & Diluted Shares Outstanding	163.30M	189.50M	204.70M	210.60M	216.78M	219.84M	221.33M	222.97M	224.53M	193.52M

This table shows Incyte's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Net Income / (Loss) Attributable to Common Shareholders	113	28	22	204	171	201	170	-445	106	201	158
Consolidated Net Income / (Loss)	113	28	22	204	171	201	170	-445	106	201	158
Net Income / (Loss) Continuing Operations	113	28	22	204	171	201	170	-445	106	201	158
Total Pre-Tax Income	149	81	52	278	234	271	236	-390	157	314	234
Total Operating Income	138	70	25	194	215	187	92	-478	146	302	205
Total Gross Profit	769	868	752	886	859	944	820	967	1,052	1,090	980
Total Revenue	823	927	809	955	919	1,013	881	1,044	1,138	1,179	1,053
Operating Revenue	823	927	809	955	919	1,013	881	1,044	1,138	1,179	1,053
Total Cost of Revenue	55	59	57	68	60	70	61	77	86	88	73
Operating Cost of Revenue	55	59	57	68	60	70	61	77	86	88	73
Total Operating Expenses	630	797	727	693	644	756	728	1,445	906	789	775
Selling, General & Admin Expense	266	273	316	284	268	294	300	306	309	327	326
Research & Development Expense	384	501	407	401	376	444	429	1,138	573	466	437
Other Operating Expenses / (Income)	1.77	-1.08	-1.36	-0.55	1.05	2.90	-1.03	0.00	0.00	-	0.00
Other Special Charges / (Income)	-22	24	6.20	8.37	-0.43	15	-0.46	0.89	23	-4.04	12
Total Other Income / (Expense), net	10	11	27	84	19	84	144	88	10	12	29
Interest Expense	0.64	0.67	0.47	0.66	0.62	0.80	0.43	0.66	0.77	0.42	0.66
Interest & Investment Income	-0.66	113	-5.32	42	-27	192	100	39	-13	119	22
Other Income / (Expense), net	12	-101	33	43	46	-108	45	50	24	-106	8.10
Income Tax Expense	36	52	30	74	63	70	67	55	50	113	76
Basic Earnings per Share	$0.51	$0.12	$0.10	$0.91	$0.76	$0.90	$0.76	($2.04)	$0.55	$0.89	$0.82
Weighted Average Basic Shares Outstanding	222.42M	222.00M	222.96M	223.25M	224.08M	223.63M	224.48M	218.18M	192.63M	207.11M	193.71M
Diluted Earnings per Share	$0.50	$0.13	$0.10	$0.90	$0.76	$0.89	$0.75	($2.04)	$0.54	$0.90	$0.80
Weighted Average Diluted Shares Outstanding	224.18M	223.96M	225.59M	225.65M	226.17M	225.93M	227.22M	218.18M	195.84M	210.53M	198.20M
Weighted Average Basic & Diluted Shares Outstanding	222.48M	222.97M	223.09M	224.09M	224.11M	224.53M	224.54M	192.60M	192.65M	193.52M	193.57M

This table details how cash moves in and out of Incyte's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	69	117	247	264	669	-319	544	894	262	-1,526
Net Cash From Operating Activities	89	305	-93	336	711	-125	749	970	496	335
Net Cash From Continuing Operating Activities	89	317	-93	336	711	-125	749	970	496	335
Net Income / (Loss) Continuing Operations	6.53	104	-313	109	447	-296	949	341	598	33
Consolidated Net Income / (Loss)	6.53	104	-313	109	447	-296	949	341	598	33
Depreciation Expense	45	58	52	55	55	52	58	68	83	89
Non-Cash Adjustments To Reconcile Net Income	73	100	225	193	133	168	208	293	195	141
Changes in Operating Assets and Liabilities, net	-35	55	-57	-21	77	-49	-465	268	-378	72
Net Cash From Investing Activities	-105	-232	-350	-86	-87	-269	-208	-79	-208	158
Net Cash From Continuing Investing Activities	-105	-232	-350	-86	-87	-269	-208	-79	-208	158
Purchase of Property, Plant & Equipment	-26	-120	-111	-73	-78	-187	-181	-78	-32	-86
Acquisitions	0.00	-143	-	-	-	-	0.00	0.00	-15	-14
Purchase of Investments	-148	-57	-385	-169	-375	-612	-269	-80	-466	-258
Sale and/or Maturity of Investments	69	88	146	156	365	531	242	79	306	516
Net Cash From Financing Activities	85	45	690	15	46	72	6.18	-0.79	-20	-2,022
Net Cash From Continuing Financing Activities	85	45	690	15	46	72	6.18	-0.79	-20	-2,022
Repurchase of Common Equity	-	-	-	-	-	-	-	0.00	0.00	-2,005
Issuance of Common Equity	86	50	716	30	80	133	59	61	36	49
Other Financing Activities, net	0.00	-4.91	-17	-15	-34	-61	-52	-62	-56	-66
Effect of Exchange Rate Changes	0.00	-0.01	-	-	-	-	-3.57	3.36	-6.68	2.92
Cash Income Taxes Paid	0.06	0.93	6.31	5.42	34	71	68	136	378	373

This table details how cash moves in and out of Incyte's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Net Change in Cash & Equivalents	255	261	-130	310	96	-14	133	-2,359	317	384	254
Net Cash From Operating Activities	296	284	-106	307	148	148	219	-576	311	381	266
Net Cash From Continuing Operating Activities	296	284	-106	307	148	148	219	-576	311	381	266
Net Income / (Loss) Continuing Operations	113	28	22	204	171	201	170	-445	106	201	158
Consolidated Net Income / (Loss)	113	28	22	204	171	201	170	-445	106	201	158
Depreciation Expense	17	18	19	20	21	22	22	22	23	23	22
Non-Cash Adjustments To Reconcile Net Income	61	30	56	12	78	49	-37	17	83	78	68
Changes in Operating Assets and Liabilities, net	106	207	-203	71	-123	-124	65	-170	98	80	18
Net Cash From Investing Activities	-28	-21	-29	-7.43	-17	-155	-73	214	38	-21	1.10
Net Cash From Continuing Investing Activities	-28	-21	-29	-7.43	-17	-155	-73	214	38	-21	1.10
Purchase of Property, Plant & Equipment	-28	-21	-12	-7.34	-11	-2.27	-9.55	-54	-5.19	-17	-3.17
Purchase of Investments	-15	-21	-55	-97	-80	-234	-166	-38	-25	-29	-41
Sale and/or Maturity of Investments	14	21	53	97	74	82	102	308	81	25	46
Net Cash From Financing Activities	-14	-2.48	4.01	13	-37	0.35	-12	-1,997	-32	20	-13
Net Cash From Continuing Financing Activities	-14	-2.48	4.01	13	-37	0.35	-12	-1,997	-32	20	-13
Issuance of Common Equity	5.30	18	14	14	-0.05	7.52	0.48	14	1.28	33	3.24
Other Financing Activities, net	-20	-21	-9.98	-1.51	-37	-7.17	-13	-6.97	-34	-13	-16
Effect of Exchange Rate Changes	1.53	0.63	-0.20	-1.89	2.72	-7.30	-0.68	0.01	0.13	3.46	-0.55
Cash Income Taxes Paid	40	20	7.11	130	116	125	2.69	227	73	70	0.84

This table presents Incyte's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Total Assets	1,007	1,639	2,303	2,646	3,427	3,561	4,933	5,841	6,782	5,444
Total Current Assets	842	994	1,505	1,832	2,481	2,360	3,119	4,093	4,645	3,239
Cash & Equivalents	521	652	900	1,164	1,833	1,513	2,057	2,951	3,213	1,688
Short-Term Investments	186	156	270	274	285	288	291	288	-	470
Accounts Receivable	114	149	266	308	309	482	616	645	744	853
Inventories, net	1.78	4.11	6.48	6.97	11	16	28	42	63	59
Prepaid Expenses	18	33	62	79	44	60	126	167	183	169
Plant, Property, & Equipment, net	86	168	260	320	378	560	724	739	752	763
Total Noncurrent Assets	79	477	538	494	568	639	1,091	1,009	1,385	1,442
Long-Term Investments	49	33	135	100	135	224	221	134	188	19
Noncurrent Note & Lease Receivables	-	-	-	-	29	28	28	26	26	31
Goodwill	0.00	156	156	156	156	156	156	156	156	156
Intangible Assets	0.00	258	237	215	194	172	151	129	124	114
Noncurrent Deferred & Refundable Income Taxes	-	-	-	-	-	-	468	458	632	762
Other Noncurrent Operating Assets	30	30	10	23	55	59	68	106	261	361
Total Liabilities & Shareholders' Equity	1,007	1,639	2,303	2,646	3,427	3,561	4,933	5,841	6,782	5,444
Total Liabilities	836	1,219	672	720	828	950	1,163	1,471	1,592	1,997
Total Current Liabilities	168	274	375	425	513	631	854	1,157	1,240	1,642
Short-Term Debt	0.00	20	34	32	52	38	37	37	38	39
Accounts Payable	30	76	68	104	84	99	172	278	110	197
Accrued Expenses	87	127	199	229	286	378	534	701	936	1,212
Current Employee Benefit Liabilities	38	51	75	60	91	113	109	139	153	189
Other Current Liabilities	-	-	-	-	0.66	2.28	2.64	3.18	3.44	4.42
Total Noncurrent Liabilities	668	946	297	295	315	318	309	314	352	355
Other Noncurrent Operating Liabilities	48	294	280	277	315	318	309	314	352	355
Total Equity & Noncontrolling Interests	171	419	1,631	1,926	2,598	2,611	3,770	4,370	5,190	3,448
Total Preferred & Common Equity	171	419	1,631	1,926	2,598	2,611	3,770	4,370	5,190	3,448
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	171	419	1,631	1,926	2,598	2,611	3,770	4,370	5,190	3,448
Common Stock	1,951	2,097	3,628	3,814	4,045	4,353	4,567	4,792	5,016	4,534
Retained Earnings	-1,779	-1,675	-1,990	-1,878	-1,431	-1,726	-778	-437	160	-1,073
Accumulated Other Comprehensive Income / (Loss)	-0.81	-2.89	-7.01	-10	-16	-15	-19	15	13	-13
Other Equity Adjustments	-	-	-	-	0.00	0.00	0.00	0.00	0.00	0.00

This table presents Incyte's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Total Assets	5,510	5,841	5,798	6,208	6,388	6,782	7,136	4,662	5,012	5,444	5,749
Total Current Assets	3,821	4,093	3,972	4,264	4,403	4,645	4,849	2,567	2,809	3,239	3,507
Cash & Equivalents	2,691	2,951	2,821	3,131	3,227	3,213	3,346	987	1,304	1,688	1,942
Short-Term Investments	287	288	292	292	289	-	504	532	471	470	467
Accounts Receivable	618	645	624	638	657	744	746	739	758	853	823
Inventories, net	46	42	41	36	57	63	64	101	70	59	64
Prepaid Expenses	180	167	194	167	172	183	189	208	205	169	212
Plant, Property, & Equipment, net	716	739	742	749	733	752	720	762	773	763	765
Total Noncurrent Assets	973	1,009	1,084	1,194	1,253	1,385	1,567	1,333	1,431	1,442	1,477
Long-Term Investments	151	134	128	170	154	188	288	30	28	19	17
Noncurrent Note & Lease Receivables	27	26	26	26	25	26	26	26	25	31	30
Goodwill	156	156	156	156	156	156	156	156	156	156	156
Intangible Assets	135	129	141	135	129	124	118	114	120	114	108
Noncurrent Deferred & Refundable Income Taxes	427	458	495	533	564	632	667	730	762	762	769
Other Noncurrent Operating Assets	79	106	139	175	225	261	313	279	340	361	397
Total Liabilities & Shareholders' Equity	5,510	5,841	5,798	6,208	6,388	6,782	7,136	4,662	5,012	5,444	5,749
Total Liabilities	1,284	1,471	1,335	1,468	1,457	1,592	1,741	1,665	1,841	1,997	2,082
Total Current Liabilities	1,007	1,157	1,006	1,119	1,125	1,240	1,396	1,337	1,502	1,642	1,720
Short-Term Debt	34	37	37	38	37	38	37	37	40	39	42
Accounts Payable	163	278	56	156	139	110	164	148	179	197	196
Accrued Expenses	700	701	825	811	821	936	1,102	1,034	1,128	1,212	1,376
Current Employee Benefit Liabilities	106	139	85	112	125	153	89	114	151	189	103
Other Current Liabilities	3.11	3.18	3.15	3.17	3.06	3.44	3.68	3.87	3.93	4.42	4.48
Total Noncurrent Liabilities	277	314	329	349	332	352	345	328	340	355	362
Capital Lease Obligations	30	-	30	-	29	-	29	-	28	-	33
Other Noncurrent Operating Liabilities	246	314	299	349	303	352	316	328	311	355	329
Commitments & Contingencies	-	-	-	-	0.00	-	0.00	0.00	0.00	-	0.00
Total Equity & Noncontrolling Interests	4,227	4,370	4,463	4,741	4,931	5,190	5,394	2,997	3,171	3,448	3,668
Total Preferred & Common Equity	4,227	4,370	4,463	4,741	4,931	5,190	5,394	2,997	3,171	3,448	3,668
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	4,227	4,370	4,463	4,741	4,931	5,190	5,394	2,997	3,171	3,448	3,668
Common Stock	4,721	4,792	4,857	4,926	4,949	5,016	5,071	4,383	4,430	4,534	4,588
Retained Earnings	-466	-437	-416	-212	-41	160	330	-1,380	-1,274	-1,073	-915
Accumulated Other Comprehensive Income / (Loss)	-29	15	21	27	23	13	-6.17	-5.42	16	-13	-6.24

This table displays calculated financial ratios and metrics derived from Incyte's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	47.36%	46.70%	38.93%	22.50%	14.71%	23.53%	11.98%	13.67%	8.87%	14.76%
EBITDA Growth	148.44%	123.66%	-185.56%	224.07%	135.57%	-137.09%	446.79%	-14.53%	28.24%	-77.21%
EBIT Growth	1,058.99%	214.73%	-256.03%	171.16%	182.13%	-152.95%	348.02%	-17.62%	29.13%	-88.31%
NOPAT Growth	1,401.89%	221.38%	-221.09%	172.00%	200.88%	-150.01%	627.75%	-61.70%	19.16%	-98.58%
Net Income Growth	113.47%	1,495.80%	-400.46%	134.97%	308.16%	-166.17%	420.79%	-64.09%	75.42%	-94.54%
EPS Growth	110.34%	1,700.00%	-383.33%	133.33%	301.96%	-166.34%	413.97%	-64.40%	74.34%	-94.34%
Operating Cash Flow Growth	2.08%	240.86%	-130.51%	461.58%	111.36%	-117.53%	701.52%	29.41%	-48.81%	-32.46%
Free Cash Flow Firm Growth	73.71%	-656.82%	-297.01%	121.04%	551.64%	-200.23%	187.87%	60.74%	-160.46%	250.17%
Invested Capital Growth	276.89%	628.66%	50.74%	15.98%	-8.75%	56.12%	98.91%	-16.45%	76.71%	-28.31%
Revenue Q/Q Growth	18.92%	8.08%	8.29%	4.69%	2.42%	8.55%	2.52%	1.92%	2.40%	4.06%
EBITDA Q/Q Growth	1,311.22%	-15.06%	-1,349.74%	4,753.14%	3.40%	23.52%	-7.22%	-20.52%	-1.90%	-20.10%
EBIT Q/Q Growth	215.02%	-22.89%	-228.39%	376.40%	4.03%	19.48%	-8.10%	-23.12%	-2.68%	-36.20%
NOPAT Q/Q Growth	256.14%	-14.51%	-253.29%	305.75%	1.10%	20.79%	76.30%	-60.96%	33.80%	200.79%
Net Income Q/Q Growth	107.63%	-30.76%	-102.50%	200.27%	10.36%	11.61%	77.44%	-61.11%	40.62%	0.41%
EPS Q/Q Growth	106.38%	-32.50%	-91.25%	204.08%	10.22%	13.38%	74.29%	-61.32%	40.21%	7.14%
Operating Cash Flow Q/Q Growth	-51.02%	36.47%	-202.57%	106.12%	7.21%	-138.02%	139.10%	21.00%	-21.49%	229.25%
Free Cash Flow Firm Q/Q Growth	-81.67%	-8.32%	-108.51%	196.31%	15.02%	-396.40%	329.19%	15.08%	-306.67%	548.26%
Invested Capital Q/Q Growth	28.90%	-4.01%	6.21%	21.37%	7.49%	0.00%	74.54%	-11.13%	37.69%	-8.87%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	96.42%	94.74%	94.83%	95.00%	94.71%	95.08%	94.94%	93.90%	93.10%	92.64%
EBITDA Margin	12.07%	18.40%	-11.33%	11.48%	23.57%	-7.07%	21.91%	16.47%	19.40%	3.85%
Operating Margin	6.72%	13.11%	-15.84%	6.87%	18.62%	-9.89%	19.62%	17.07%	16.79%	1.45%
EBIT Margin	6.11%	13.11%	-14.73%	8.55%	21.04%	-9.02%	19.97%	14.47%	17.17%	1.75%
Profit (Net Income) Margin	0.87%	9.43%	-20.38%	5.82%	20.70%	-11.09%	31.76%	10.04%	16.17%	0.77%
Tax Burden Percent	86.43%	97.04%	100.27%	94.92%	91.81%	127.34%	166.29%	64.38%	71.64%	10.30%
Interest Burden Percent	16.40%	74.07%	138.04%	71.65%	107.18%	96.57%	95.64%	107.69%	131.48%	426.87%
Effective Tax Rate	13.57%	2.96%	0.00%	5.08%	8.19%	0.00%	-66.29%	35.62%	28.36%	89.70%
Return on Invested Capital (ROIC)	587.53%	99.05%	-54.40%	30.16%	88.37%	-36.17%	104.75%	32.85%	31.07%	0.40%
ROIC Less NNEP Spread (ROIC-NNEP)	687.36%	122.85%	-34.34%	31.12%	84.15%	-30.86%	105.88%	33.95%	26.50%	-0.55%
Return on Net Nonoperating Assets (RNNOA)	-572.94%	-63.75%	23.85%	-24.01%	-68.62%	24.81%	-75.02%	-24.48%	-18.57%	0.35%
Return on Equity (ROE)	14.59%	35.29%	-30.55%	6.16%	19.76%	-11.35%	29.73%	8.37%	12.50%	0.76%
Cash Return on Invested Capital (CROIC)	-28.84%	-52.68%	-94.87%	15.37%	97.53%	-79.99%	38.58%	50.77%	-24.37%	33.38%
Operating Return on Assets (OROA)	5.11%	10.96%	-11.48%	6.51%	14.96%	-6.88%	14.04%	9.12%	10.05%	1.21%
Return on Assets (ROA)	0.72%	7.88%	-15.89%	4.43%	14.72%	-8.46%	22.33%	6.32%	9.47%	0.53%
Return on Common Equity (ROCE)	14.59%	35.29%	-30.55%	6.16%	19.76%	-11.35%	29.73%	8.37%	12.50%	0.76%
Return on Equity Simple (ROE_SIMPLE)	3.82%	24.85%	-19.20%	5.69%	17.20%	-11.32%	25.16%	7.80%	11.51%	0.95%
Net Operating Profit after Tax (NOPAT)	44	141	-170	123	369	-185	974	373	445	6.32
NOPAT Margin	5.81%	12.73%	-11.09%	6.52%	17.10%	-6.92%	32.62%	10.99%	12.03%	0.15%
Net Nonoperating Expense Percent (NNEP)	-99.83%	-23.80%	-20.06%	-0.96%	4.22%	-5.31%	-1.13%	-1.10%	4.57%	0.96%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	8.47%	8.50%	0.18%
Cost of Revenue to Revenue	3.58%	5.26%	5.17%	5.00%	5.29%	4.92%	5.06%	6.10%	6.90%	7.36%
SG&A Expenses to Revenue	26.08%	27.43%	23.84%	23.08%	21.71%	19.38%	24.77%	29.52%	31.42%	29.29%
R&D to Revenue	63.62%	52.62%	86.32%	63.66%	53.46%	83.10%	48.83%	46.72%	44.04%	61.46%
Operating Expenses to Revenue	89.70%	81.62%	110.67%	88.13%	76.09%	104.96%	75.33%	76.83%	76.31%	91.20%
Earnings before Interest and Taxes (EBIT)	46	145	-226	161	454	-240	596	491	634	74
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	91	203	-174	216	509	-189	654	559	717	163
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	117.86	45.03	12.26	7.03	7.24	7.29	4.30	4.09	2.71	3.86
Price to Tangible Book Value (P/TBV)	117.86	3,474.23	16.14	8.70	8.36	8.34	4.68	4.37	2.87	4.19
Price to Revenue (P/Rev)	26.76	17.08	13.01	7.19	8.71	7.14	5.43	5.26	3.81	3.14
Price to Earnings (P/E)	3,088.64	181.24	0.00	123.59	42.09	0.00	17.09	52.45	23.55	407.98
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.03%	0.55%	0.00%	0.81%	2.38%	0.00%	5.85%	1.91%	4.25%	0.25%
Enterprise Value to Invested Capital (EV/IC)	584.33	74.93	49.75	27.57	41.68	27.42	11.05	14.06	5.86	8.53
Enterprise Value to Revenue (EV/Rev)	26.58	16.93	12.19	6.40	7.69	6.40	4.58	4.28	2.90	2.63
Enterprise Value to EBITDA (EV/EBITDA)	220.27	92.02	0.00	55.77	32.65	0.00	20.91	25.99	14.93	68.34
Enterprise Value to EBIT (EV/EBIT)	434.87	129.10	0.00	74.81	36.57	0.00	22.94	29.58	16.88	150.57
Enterprise Value to NOPAT (EV/NOPAT)	457.61	133.04	0.00	98.18	45.00	0.00	14.05	38.96	24.09	1,766.89
Enterprise Value to Operating Cash Flow (EV/OCF)	224.08	61.42	0.00	35.82	23.37	0.00	18.25	14.98	21.57	33.31
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	192.68	40.78	0.00	38.14	25.21	0.00	21.33
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	3.62	1.60	0.03	0.03	0.02	0.01	0.01	0.01	0.01	0.01
Long-Term Debt to Equity	3.62	1.55	0.01	0.01	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.83	-0.52	-0.69	-0.77	-0.82	-0.80	-0.71	-0.72	-0.70	-0.64
Leverage Ratio	20.15	4.48	1.92	1.39	1.34	1.34	1.33	1.32	1.32	1.42
Compound Leverage Factor	3.30	3.32	2.65	1.00	1.44	1.30	1.27	1.43	1.74	6.04
Debt to Total Capital	78.36%	61.53%	3.02%	2.49%	1.97%	1.45%	0.97%	0.83%	0.73%	1.13%
Short-Term Debt to Total Capital	0.00%	1.79%	2.04%	1.61%	1.97%	1.45%	0.97%	0.83%	0.73%	1.13%
Long-Term Debt to Total Capital	78.36%	59.74%	0.99%	0.88%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	21.64%	38.47%	96.98%	97.51%	98.03%	98.55%	99.03%	99.17%	99.27%	98.87%
Debt to EBITDA	6.82	3.30	-0.29	0.23	0.10	-0.20	0.06	0.07	0.05	0.24
Net Debt to EBITDA	-1.51	-0.84	7.21	-6.90	-4.32	10.53	-3.87	-5.97	-4.69	-13.08
Long-Term Debt to EBITDA	6.82	3.20	-0.10	0.08	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	14.16	4.77	-0.30	0.40	0.14	-0.21	0.04	0.10	0.09	6.21
Net Debt to NOPAT	-3.14	-1.21	7.36	-12.14	-5.96	10.77	-2.60	-8.94	-7.56	-338.18
Long-Term Debt to NOPAT	14.16	4.63	-0.10	0.14	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	13.70	9.36	17.57	11.84	14.80	12.46	9.70	8.65	6.79	4.90
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	5.01	3.64	4.01	4.31	4.83	3.74	3.65	3.54	3.75	1.97
Quick Ratio	4.89	3.50	3.83	4.11	4.73	3.62	3.47	3.36	3.19	1.83
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-9.89	-75	-297	63	407	-408	359	577	-349	524
Operating Cash Flow to CapEx	343.84%	253.38%	-83.76%	457.56%	910.35%	-66.50%	414.07%	1,246.18%	1,528.31%	388.74%
Free Cash Flow to Firm to Interest Expense	-0.22	-1.93	-4.81	40.51	219.57	-187.78	188.00	216.28	-136.66	229.62
Operating Cash Flow to Interest Expense	1.96	7.87	-1.51	217.90	383.10	-57.31	392.81	363.82	194.62	147.08
Operating Cash Flow Less CapEx to Interest Expense	1.39	4.76	-3.30	170.28	341.02	-143.50	297.95	334.62	181.89	109.24
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.84	0.84	0.78	0.76	0.71	0.76	0.70	0.63	0.59	0.69
Accounts Receivable Turnover	8.75	8.40	7.40	6.56	7.00	6.74	5.44	5.38	5.32	5.31
Inventory Turnover	25.20	19.76	15.01	14.00	12.44	9.44	6.81	5.92	4.86	5.12
Fixed Asset Turnover	8.98	8.72	7.19	6.49	6.19	5.69	4.65	4.64	4.96	5.60
Accounts Payable Turnover	0.99	1.10	1.11	1.10	1.22	1.44	1.11	0.92	1.32	2.03
Days Sales Outstanding (DSO)	41.74	43.44	49.31	55.66	52.11	54.12	67.12	67.80	68.56	68.71
Days Inventory Outstanding (DIO)	14.49	18.47	24.31	26.08	29.34	38.67	53.58	61.63	75.13	71.26
Days Payable Outstanding (DPO)	369.08	331.47	328.98	332.53	299.47	253.49	327.40	396.44	277.09	179.57
Cash Conversion Cycle (CCC)	-312.86	-269.56	-255.36	-250.79	-218.02	-160.70	-206.70	-267.01	-133.40	-39.61
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	34	250	377	437	399	622	1,238	1,034	1,827	1,310
Invested Capital Turnover	101.15	7.78	4.90	4.63	5.17	5.23	3.21	2.99	2.58	2.70
Increase / (Decrease) in Invested Capital	54	216	127	60	-38	224	615	-204	793	-517
Enterprise Value (EV)	20,034	18,719	18,733	12,043	16,609	17,061	13,681	14,533	10,709	11,169
Market Capitalization	20,172	18,889	19,987	13,532	18,808	19,048	16,213	17,869	14,072	13,306
Book Value per Share	$0.92	$2.23	$7.73	$9.05	$12.06	$11.92	$17.07	$19.64	$23.16	$17.90
Tangible Book Value per Share	$0.92	$0.03	$5.87	$7.31	$10.44	$10.43	$15.68	$18.36	$21.91	$16.50
Total Capital	791	1,090	1,681	1,975	2,651	2,650	3,807	4,407	5,228	3,487
Total Debt	620	671	51	49	52	38	37	37	38	39
Total Long-Term Debt	620	651	17	17	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-138	-170	-1,254	-1,489	-2,200	-1,987	-2,532	-3,336	-3,363	-2,138
Capital Expenditures (CapEx)	26	120	111	73	78	187	181	78	32	86
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-34	-68	-5.95	0.50	-97	-34	-47	-267	230	-522
Debt-free Net Working Capital (DFNWC)	674	740	1,164	1,439	2,020	1,767	2,301	2,972	3,443	1,636
Net Working Capital (NWC)	674	721	1,129	1,407	1,968	1,729	2,264	2,936	3,405	1,597
Net Nonoperating Expense (NNE)	37	36	143	13	-78	111	25	32	-153	-26
Net Nonoperating Obligations (NNO)	-137	-170	-1,254	-1,489	-2,200	-1,989	-2,532	-3,336	-3,363	-2,138
Total Depreciation and Amortization (D&A)	45	58	52	55	55	52	58	68	83	89
Debt-free, Cash-free Net Working Capital to Revenue	-4.50%	-6.18%	-0.39%	0.03%	-4.50%	-1.29%	-1.57%	-7.86%	6.23%	-12.30%
Debt-free Net Working Capital to Revenue	89.47%	66.94%	75.75%	76.46%	93.60%	66.27%	77.07%	87.56%	93.18%	38.58%
Net Working Capital to Revenue	89.47%	65.18%	73.52%	74.76%	91.17%	64.83%	75.83%	86.48%	92.14%	37.66%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.04	$0.55	($1.53)	$0.52	$2.08	($1.36)	$4.30	$1.53	$2.67	$0.16
Adjusted Weighted Average Basic Shares Outstanding	179.60M	187.87M	204.58M	212.38M	214.91M	218.07M	220.43M	222.00M	223.63M	207.11M
Adjusted Diluted Earnings per Share	$0.03	$0.54	($1.53)	$0.51	$2.05	($1.36)	$4.27	$1.52	$2.65	$0.15
Adjusted Weighted Average Diluted Shares Outstanding	187.30M	194.13M	204.58M	215.64M	217.66M	218.07M	222.07M	223.96M	225.93M	210.53M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	187.20M	189.41M	211.66M	214.05M	216.78M	219.84M	221.33M	222.97M	224.53M	193.52M
Normalized Net Operating Profit after Tax (NOPAT)	44	158	-165	148	387	-168	420	381	465	57
Normalized NOPAT Margin	5.81%	14.25%	-10.74%	7.84%	17.93%	-6.31%	14.08%	11.22%	12.59%	1.34%
Pre Tax Income Margin	1.00%	9.71%	-20.33%	6.13%	22.55%	-8.71%	19.10%	15.59%	22.57%	7.47%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	1.01	3.74	-3.66	104.33	244.85	-110.61	312.59	184.30	248.71	32.53
NOPAT to Interest Expense	0.96	3.63	-2.76	79.50	198.96	-84.90	510.52	139.93	174.25	2.77
EBIT Less CapEx to Interest Expense	0.44	0.64	-5.46	56.71	202.76	-196.80	217.72	155.10	235.98	-5.30
NOPAT Less CapEx to Interest Expense	0.39	0.53	-4.55	31.87	156.88	-171.09	415.66	110.74	161.52	-35.06
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	6,146.83%

This table displays calculated financial ratios and metrics derived from Incyte's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	1.27%	7.40%	10.29%	4.74%	11.63%	9.35%	8.93%	9.34%	23.81%	16.32%	19.53%
EBITDA Growth	-33.91%	-109.97%	-42.75%	-5.42%	69.57%	871.82%	106.35%	-258.26%	-31.74%	116.07%	110.72%
EBIT Growth	-36.85%	-126.89%	-51.07%	-7.26%	74.18%	353.24%	137.05%	-281.17%	-34.78%	146.70%	137.30%
NOPAT Growth	-48.58%	-95.24%	-83.48%	-20.65%	49.76%	461.60%	536.43%	-335.56%	-36.83%	39.15%	110.07%
Net Income Growth	-37.95%	-94.95%	-42.87%	26.09%	51.87%	606.51%	681.22%	-318.43%	-37.84%	0.07%	-6.69%
EPS Growth	-39.02%	-94.88%	-41.18%	25.00%	52.00%	584.62%	650.00%	-326.67%	-28.95%	1.12%	6.67%
Operating Cash Flow Growth	16.18%	145.91%	-148.95%	76.01%	-50.12%	-47.92%	307.20%	-287.77%	110.28%	158.05%	21.60%
Free Cash Flow Firm Growth	30.78%	339.92%	87.90%	151.87%	98.21%	-386.56%	148.86%	-408.88%	-78.40%	208.62%	347.30%
Invested Capital Growth	64.09%	-16.45%	6.32%	-5.10%	14.06%	76.71%	2.61%	25.38%	8.33%	-28.31%	-0.47%
Revenue Q/Q Growth	-9.67%	12.56%	-12.74%	18.05%	-3.73%	10.26%	-13.07%	18.49%	9.02%	3.59%	-10.67%
EBITDA Q/Q Growth	-38.64%	-107.86%	-33.14%	234.07%	10.02%	-64.22%	-38.88%	-356.21%	147.45%	13.25%	7.91%
EBIT Q/Q Growth	-41.21%	-120.89%	-40.41%	310.19%	10.42%	-69.63%	-42.52%	-413.49%	139.75%	14.88%	9.02%
NOPAT Q/Q Growth	-41.35%	-76.44%	-58.11%	1,270.58%	10.70%	-11.64%	-52.53%	-607.28%	129.69%	94.63%	-28.33%
Net Income Q/Q Growth	-30.14%	-74.76%	-23.74%	837.88%	-15.86%	17.41%	-15.68%	-362.23%	123.94%	89.01%	-21.38%
EPS Q/Q Growth	-30.56%	-74.00%	-23.08%	800.00%	-15.56%	17.11%	-15.73%	-372.00%	126.47%	66.67%	-11.11%
Operating Cash Flow Q/Q Growth	70.18%	-4.29%	-137.23%	390.26%	-51.77%	-0.07%	48.12%	-363.04%	154.01%	22.63%	-30.21%
Free Cash Flow Firm Q/Q Growth	11.88%	165.33%	-129.02%	410.45%	-103.04%	-10,354.65%	115.31%	-2,062.49%	98.24%	6,465.65%	-79.62%
Invested Capital Q/Q Growth	-6.78%	-11.13%	24.60%	-8.06%	12.03%	37.69%	-4.51%	12.34%	-3.21%	-8.87%	0.45%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	93.37%	93.62%	92.97%	92.84%	93.46%	93.12%	93.08%	92.66%	92.44%	92.49%	93.05%
EBITDA Margin	20.23%	-1.41%	9.50%	26.90%	30.74%	9.97%	18.00%	-38.93%	16.94%	18.52%	22.38%
Operating Margin	16.81%	7.56%	3.06%	20.30%	23.36%	18.48%	10.43%	-45.81%	12.84%	25.58%	19.49%
EBIT Margin	18.21%	-3.38%	7.13%	24.77%	28.41%	7.82%	15.51%	-41.04%	14.96%	16.60%	20.26%
Profit (Net Income) Margin	13.70%	3.07%	2.68%	21.32%	18.64%	19.84%	19.25%	-42.60%	9.36%	17.07%	15.03%
Tax Burden Percent	75.90%	35.30%	41.85%	73.32%	73.25%	74.21%	71.79%	114.07%	68.01%	64.14%	67.55%
Interest Burden Percent	99.13%	-257.47%	89.96%	117.41%	89.55%	341.72%	172.83%	90.99%	91.92%	160.38%	109.81%
Effective Tax Rate	24.10%	64.70%	58.15%	26.68%	26.75%	25.79%	28.21%	0.00%	31.99%	35.86%	32.45%
Return on Invested Capital (ROIC)	45.38%	7.98%	3.56%	42.99%	49.60%	35.43%	21.62%	-92.65%	25.75%	44.36%	44.05%
ROIC Less NNEP Spread (ROIC-NNEP)	45.10%	7.85%	3.17%	41.07%	49.18%	33.57%	18.76%	-88.32%	25.48%	44.08%	43.44%
Return on Net Nonoperating Assets (RNNOA)	-33.65%	-5.66%	-2.22%	-29.75%	-35.81%	-23.53%	-13.79%	57.85%	-16.79%	-28.07%	-30.79%
Return on Equity (ROE)	11.73%	2.32%	1.34%	13.24%	13.79%	11.90%	7.83%	-34.81%	8.96%	16.29%	13.25%
Cash Return on Invested Capital (CROIC)	53.52%	50.77%	18.66%	28.26%	13.55%	-24.37%	35.99%	-22.20%	-8.45%	33.38%	1.37%
Operating Return on Assets (OROA)	12.49%	-2.13%	4.56%	15.10%	17.23%	4.58%	9.04%	-29.12%	10.70%	11.51%	13.88%
Return on Assets (ROA)	9.40%	1.94%	1.72%	13.00%	11.31%	11.62%	11.21%	-30.23%	6.69%	11.84%	10.29%
Return on Common Equity (ROCE)	11.73%	2.32%	1.34%	13.24%	13.79%	11.90%	7.83%	-34.81%	8.96%	16.29%	13.25%
Return on Equity Simple (ROE_SIMPLE)	20.73%	0.00%	7.27%	7.73%	8.62%	0.00%	13.82%	3.25%	1.02%	0.00%	0.58%
Net Operating Profit after Tax (NOPAT)	105	25	10	142	157	139	66	-335	99	193	139
NOPAT Margin	12.76%	2.67%	1.28%	14.88%	17.11%	13.71%	7.49%	-32.07%	8.73%	16.41%	13.16%
Net Nonoperating Expense Percent (NNEP)	0.28%	0.13%	0.39%	1.92%	0.42%	1.85%	2.86%	-4.34%	0.27%	0.28%	0.61%
Return On Investment Capital (ROIC_SIMPLE)	-	0.56%	-	-	-	2.66%	-	-	-	5.55%	3.70%
Cost of Revenue to Revenue	6.63%	6.38%	7.03%	7.16%	6.54%	6.88%	6.92%	7.34%	7.56%	7.51%	6.95%
SG&A Expenses to Revenue	32.36%	29.44%	39.03%	29.74%	29.15%	29.00%	34.09%	29.32%	27.17%	27.72%	30.93%
R&D to Revenue	46.64%	54.10%	50.29%	41.98%	40.88%	43.86%	48.73%	109.07%	50.37%	39.54%	41.53%
Operating Expenses to Revenue	76.56%	86.05%	89.91%	72.54%	70.10%	74.64%	82.65%	138.47%	79.60%	66.91%	73.56%
Earnings before Interest and Taxes (EBIT)	150	-31	58	236	261	79	137	-428	170	196	213
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	167	-13	77	257	282	101	159	-406	193	218	236
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.51	4.09	3.61	2.93	2.63	2.71	0.00	4.54	4.01	3.86	3.20
Price to Tangible Book Value (P/TBV)	3.77	4.37	3.87	3.12	2.79	2.87	0.00	4.99	4.40	4.19	3.44
Price to Revenue (P/Rev)	4.45	5.26	4.64	3.95	3.59	3.81	0.00	3.53	3.12	3.14	2.66
Price to Earnings (P/E)	16.92	52.45	49.68	37.89	30.46	23.55	0.00	139.90	391.93	407.98	550.91
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	5.91%	1.91%	2.01%	2.64%	3.28%	4.25%	0.00%	0.71%	0.26%	0.25%	0.18%
Enterprise Value to Invested Capital (EV/IC)	10.11	14.06	10.04	8.72	7.04	5.86	0.00	8.15	7.65	8.53	7.12
Enterprise Value to Revenue (EV/Rev)	3.53	4.28	3.73	2.94	2.59	2.90	0.00	3.14	2.70	2.63	2.12
Enterprise Value to EBITDA (EV/EBITDA)	16.71	25.99	20.54	16.80	12.78	14.93	0.00	41.13	53.76	68.34	32.61
Enterprise Value to EBIT (EV/EBIT)	18.40	29.58	23.14	19.11	14.33	16.88	0.00	58.44	94.58	150.57	47.41
Enterprise Value to NOPAT (EV/NOPAT)	12.31	38.96	41.75	36.88	28.12	24.09	0.00	2,773.80	0.00	1,766.89	793.42
Enterprise Value to Operating Cash Flow (EV/OCF)	14.67	14.98	19.95	13.23	14.77	21.57	0.00	0.00	107.98	33.31	24.48
Enterprise Value to Free Cash Flow (EV/FCFF)	23.47	25.21	55.47	30.06	55.37	0.00	0.00	0.00	0.00	21.33	519.86
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.02	0.01	0.02	0.01	0.01	0.01	0.01	0.01	0.02	0.01	0.02
Long-Term Debt to Equity	0.01	0.00	0.01	0.00	0.01	0.00	0.01	0.00	0.01	0.00	0.01
Financial Leverage	-0.75	-0.72	-0.70	-0.72	-0.73	-0.70	-0.74	-0.66	-0.66	-0.64	-0.71
Leverage Ratio	1.32	1.32	1.30	1.31	1.30	1.32	1.31	1.40	1.41	1.42	1.42
Compound Leverage Factor	1.31	-3.41	1.17	1.53	1.16	4.51	2.27	1.28	1.29	2.27	1.56
Debt to Total Capital	1.51%	0.83%	1.48%	0.79%	1.31%	0.73%	1.21%	1.22%	2.12%	1.13%	1.99%
Short-Term Debt to Total Capital	0.80%	0.83%	0.82%	0.79%	0.74%	0.73%	0.68%	1.22%	1.25%	1.13%	1.11%
Long-Term Debt to Total Capital	0.71%	0.00%	0.66%	0.00%	0.58%	0.00%	0.53%	0.00%	0.87%	0.00%	0.87%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	98.49%	99.17%	98.52%	99.22%	98.69%	99.27%	98.79%	98.78%	97.88%	98.87%	98.01%
Debt to EBITDA	0.09	0.07	0.11	0.06	0.09	0.05	0.07	0.13	0.34	0.24	0.26
Net Debt to EBITDA	-4.35	-5.97	-5.04	-5.78	-4.93	-4.69	-4.25	-5.14	-8.48	-13.08	-8.19
Long-Term Debt to EBITDA	0.04	0.00	0.05	0.00	0.04	0.00	0.03	0.00	0.14	0.00	0.11
Debt to NOPAT	0.07	0.10	0.22	0.13	0.20	0.09	0.13	8.52	-10.93	6.21	6.30
Net Debt to NOPAT	-3.21	-8.94	-10.24	-12.69	-10.85	-7.56	-8.09	-346.59	276.44	-338.18	-199.22
Long-Term Debt to NOPAT	0.03	0.00	0.10	0.00	0.09	0.00	0.06	0.00	-4.50	0.00	2.77
Altman Z-Score	8.12	8.35	8.39	6.93	6.64	6.52	0.00	5.33	5.03	4.97	4.42
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.80	3.54	3.95	3.81	3.91	3.75	3.47	1.92	1.87	1.97	2.04
Quick Ratio	3.57	3.36	3.71	3.63	3.71	3.19	3.29	1.69	1.69	1.83	1.88
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-349	228	-66	206	-6.26	-654	32	-635	-11	711	145
Operating Cash Flow to CapEx	1,065.70%	1,333.44%	-886.97%	4,177.81%	1,346.89%	6,516.50%	2,291.45%	-1,063.04%	5,993.27%	2,192.92%	8,395.93%
Free Cash Flow to Firm to Interest Expense	-545.11	342.25	-141.27	314.03	-10.04	-813.65	75.29	-967.04	-14.42	1,695.91	219.41
Operating Cash Flow to Interest Expense	462.37	425.28	-225.17	467.98	237.30	183.74	508.86	-876.05	401.64	909.83	403.13
Operating Cash Flow Less CapEx to Interest Expense	418.99	393.39	-250.55	456.78	219.68	180.92	486.66	-958.46	394.94	868.34	398.33
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.69	0.63	0.64	0.61	0.61	0.59	0.58	0.71	0.72	0.69	0.69
Accounts Receivable Turnover	5.87	5.38	5.85	5.32	5.66	5.32	5.50	5.60	5.76	5.31	5.63
Inventory Turnover	5.71	5.92	5.80	5.28	4.74	4.86	4.96	3.91	4.60	5.12	5.08
Fixed Asset Turnover	4.75	4.64	4.72	4.78	4.98	4.96	5.16	5.10	5.41	5.60	5.94
Accounts Payable Turnover	1.38	0.92	2.13	1.36	1.62	1.32	2.36	1.76	1.84	2.03	1.80
Days Sales Outstanding (DSO)	62.18	67.80	62.38	68.62	64.50	68.56	66.32	65.16	63.39	68.71	64.87
Days Inventory Outstanding (DIO)	63.95	61.63	62.98	69.09	76.96	75.13	73.61	93.25	79.41	71.26	71.82
Days Payable Outstanding (DPO)	264.35	396.44	171.75	267.61	225.95	277.09	154.85	207.26	197.92	179.57	202.46
Cash Conversion Cycle (CCC)	-138.22	-267.01	-46.40	-129.90	-84.49	-133.40	-14.92	-48.86	-55.12	-39.61	-65.78
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,163	1,034	1,288	1,185	1,327	1,827	1,322	1,485	1,438	1,310	1,316
Invested Capital Turnover	3.56	2.99	2.78	2.89	2.90	2.58	2.89	2.89	2.95	2.70	3.35
Increase / (Decrease) in Invested Capital	454	-204	77	-64	164	793	34	301	111	-517	-6.21
Enterprise Value (EV)	11,760	14,533	12,940	10,331	9,341	10,709	0.00	12,100	10,997	11,169	9,366
Market Capitalization	14,823	17,869	16,114	13,887	12,946	14,072	0.00	13,612	12,731	13,306	11,718
Book Value per Share	$19.00	$19.64	$20.01	$21.25	$22.01	$23.16	$24.03	$13.35	$16.47	$17.90	$18.95
Tangible Book Value per Share	$17.70	$18.36	$18.69	$19.95	$20.74	$21.91	$22.81	$12.15	$15.03	$16.50	$17.59
Total Capital	4,291	4,407	4,529	4,778	4,997	5,228	5,460	3,034	3,240	3,487	3,742
Total Debt	65	37	67	38	66	38	66	37	69	39	74
Total Long-Term Debt	30	0.00	30	0.00	29	0.00	29	0.00	28	0.00	33
Net Debt	-3,063	-3,336	-3,174	-3,556	-3,604	-3,363	-4,072	-1,512	-1,734	-2,138	-2,352
Capital Expenditures (CapEx)	28	21	12	7.34	11	2.27	9.55	54	5.19	17	3.17
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-128	-267	-110	-240	-202	230	-361	-252	-427	-522	-580
Debt-free Net Working Capital (DFNWC)	2,849	2,972	3,003	3,183	3,315	3,443	3,490	1,267	1,347	1,636	1,829
Net Working Capital (NWC)	2,815	2,936	2,966	3,146	3,278	3,405	3,453	1,230	1,307	1,597	1,787
Net Nonoperating Expense (NNE)	-7.75	-3.71	-11	-61	-14	-62	-104	110	-7.10	-7.83	-20
Net Nonoperating Obligations (NNO)	-3,063	-3,336	-3,174	-3,556	-3,604	-3,363	-4,072	-1,512	-1,734	-2,138	-2,352
Total Depreciation and Amortization (D&A)	17	18	19	20	21	22	22	22	23	23	22
Debt-free, Cash-free Net Working Capital to Revenue	-3.86%	-7.86%	-3.17%	-6.84%	-5.59%	6.23%	-9.58%	-6.54%	-10.48%	-12.30%	-13.14%
Debt-free Net Working Capital to Revenue	85.53%	87.56%	86.53%	90.60%	91.85%	93.18%	92.62%	32.85%	33.06%	38.58%	41.44%
Net Working Capital to Revenue	84.50%	86.48%	85.46%	89.54%	90.83%	92.14%	91.63%	31.89%	32.07%	37.66%	40.49%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.51	$0.12	$0.10	$0.91	$0.76	$0.90	$0.76	($2.04)	$0.55	$0.89	$0.82
Adjusted Weighted Average Basic Shares Outstanding	222.42M	222.00M	222.96M	223.25M	224.08M	223.63M	224.48M	218.18M	192.63M	207.11M	193.71M
Adjusted Diluted Earnings per Share	$0.50	$0.13	$0.10	$0.90	$0.76	$0.89	$0.75	($2.04)	$0.54	$0.90	$0.80
Adjusted Weighted Average Diluted Shares Outstanding	224.18M	223.96M	225.59M	225.65M	226.17M	225.93M	227.22M	218.18M	195.84M	210.53M	198.20M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	222.48M	222.97M	223.09M	224.09M	224.11M	224.53M	224.54M	192.60M	192.65M	193.52M	193.57M
Normalized Net Operating Profit after Tax (NOPAT)	88	66	22	148	157	150	66	-334	115	191	146
Normalized NOPAT Margin	10.74%	7.13%	2.68%	15.53%	17.08%	14.82%	7.45%	-32.01%	10.13%	16.19%	13.91%
Pre Tax Income Margin	18.05%	8.70%	6.41%	29.08%	25.44%	26.74%	26.81%	-37.34%	13.76%	26.62%	22.24%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	233.84	-46.94	122.91	360.99	419.06	98.62	317.77	-652.00	220.00	466.86	323.13
NOPAT to Interest Expense	163.84	37.10	22.10	216.92	252.46	172.85	153.44	-509.42	128.37	461.53	210.00
EBIT Less CapEx to Interest Expense	190.45	-78.84	97.52	349.79	401.44	95.80	295.57	-734.40	213.30	425.37	318.33
NOPAT Less CapEx to Interest Expense	120.46	5.21	-3.28	205.72	234.84	170.03	131.23	-591.83	121.67	420.04	205.20
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	6,146.83%	0.00%

Frequently Asked Questions About Incyte's Financials

When does Incyte's fiscal year end?

According to the most recent income statement we have on file, Incyte's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Incyte's net income changed over the last 9 years?

Incyte's net income appears to be on an upward trend, with a most recent value of $32.62 million in 2024, rising from $6.53 million in 2015. The previous period was $597.60 million in 2023. Find out what analysts predict for Incyte in the coming months.

What is Incyte's operating income?

Incyte's total operating income in 2024 was $61.37 million, based on the following breakdown:

Total Gross Profit: $3.93 billion
Total Operating Expenses: $3.87 billion

How has Incyte revenue changed over the last 9 years?

Over the last 9 years, Incyte's total revenue changed from $753.75 million in 2015 to $4.24 billion in 2024, a change of 462.7%.

How much debt does Incyte have?

Incyte's total liabilities were at $2.00 billion at the end of 2024, a 25.4% increase from 2023, and a 138.8% increase since 2015.

How much cash does Incyte have?

In the past 9 years, Incyte's cash and equivalents has ranged from $521.44 million in 2015 to $3.21 billion in 2023, and is currently $1.69 billion as of their latest financial filing in 2024.

How has Incyte's book value per share changed over the last 9 years?

Over the last 9 years, Incyte's book value per share changed from 0.92 in 2015 to 17.90 in 2024, a change of 1,844.8%.

Related Companies

This page (NASDAQ:INCY) was last updated on 5/5/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Incyte (INCY) Financials

Frequently Asked Questions About Incyte's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Incyte (INCY) Financials

Annual Income Statements for Incyte

Quarterly Income Statements for Incyte

Annual Cash Flow Statements for Incyte

Quarterly Cash Flow Statements for Incyte

Annual Balance Sheets for Incyte

Quarterly Balance Sheets for Incyte

Annual Metrics and Ratios for Incyte

Quarterly Metrics and Ratios for Incyte

Frequently Asked Questions About Incyte's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools